2018
DOI: 10.1109/tcbb.2017.2748944
|View full text |Cite
|
Sign up to set email alerts
|

Integrating Imaging Genomic Data in the Quest for Biomarkers of Schizophrenia Disease

Abstract: It's increasingly important but difficult to determine potential biomarkers of schizophrenia (SCZ) disease, owing to the complex pathophysiology of this disease. In this study, a network-fusion based framework was proposed to identify genetic biomarkers of the SCZ disease. A three-step feature selection was applied to single nucleotide polymorphisms (SNPs), DNA methylation, and functional magnetic resonance imaging (fMRI) data to select important features, which were then used to construct two gene networks in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 92 publications
(58 reference statements)
1
5
0
Order By: Relevance
“…The connections were found to be reduced by schizophrenia, as shown in Figure 4. This finding was consistent with studies using other imaging modalities (Bellani et al, 2010;Deng et al, 2017).…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…The connections were found to be reduced by schizophrenia, as shown in Figure 4. This finding was consistent with studies using other imaging modalities (Bellani et al, 2010;Deng et al, 2017).…”
Section: Discussionsupporting
confidence: 92%
“…Conventionally, clinical diagnostic criteria are predominately based on the relative subjective approaches, for example, according to the diagnostic manuals (American Psychiatric Association, 1994 ). With the development of neuroimaging, a number of objective methods to identify schizophrenia patients have emerged, e.g., single photon emission computed tomography (SPECT; Gordon et al, 1994 ), diffusion tensor imaging (DTI; Ohtani et al, 2014 ), functional magnetic resonance imaging (fMRI; Weiss et al, 2004 ; Deng et al, 2017 ; Tréhout et al, 2017 ), and functional near infrared spectroscopy (fNIRS; Kubota et al, 2005 ; Rosenbaum et al, 2017 ).…”
Section: Introductionmentioning
confidence: 99%
“…Those methods aim to discard redundant genes from expression data sets and keep only a smaller subset of relevant genes that effectively participate in sample classification. These relevant and non-redundant genes are often recognized as disease-related genes or gene-markers [5][6][7], and they have a significant impact on genetic studies. Existing research indicates that genetic markers are highly involved in different cancer pathways; hence they can be useful for diagnosing and assessing drug efficacy and toxicity.…”
Section: Introductionmentioning
confidence: 99%
“…In this paper, two-modality data were generated, the datasets use fMRI data of 116 brain regions, which has a dataset of 183 examples, and every example includes more than forty thousand features, and use SNPs dataset of specific genes [5], [6]. For the purposes of correlation analysis validation between fMRI and SNPs data, various modified CCA algorithms and different deep networks were simultaneously applied on the datasets.…”
Section: Introductionmentioning
confidence: 99%